Actinium Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q3 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Actinium Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q3 2023 to Q1 2024.
  • Actinium Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending March 31, 2024 was $643K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $643K Mar 31, 2024 10-Q 2024-04-26
Q3 2023 $643K Sep 30, 2023 10-K 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.